Merck Animal Health Receives S&P Global Awards for NUMELVI® and INNOVAX® ND-ILT-IBD
24 February 2026, Rahway: Merck Animal Health, known as MSD Animal Health outside of the United States and Canada and a
Read More
NUMELVI
Latest news and updates on NUMELVI – a highly-selective, second-generation JAK inhibitor for dogs, delivers at least 10-fold greater selectivity for JAK1 compared with JAK2, JAK3, and tyrosine kinase (TYK)–2, and is suitable for dogs as young as 6 months